Thymoquinone: Potential cure for inflammatory disorders and cancer

Biochemical Pharmacology

Volumn 83, Issue 4, 2012, Pages 443-451

  Woo, Chern Chiuh ^a   Kumar, Alan Prem ^a,b,c   Sethi, Gautam ^a,b   Tan, Kwong Huat Benny ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apoptosis; Cancer; Drug toxicity; Inflammatory disorders; Thymoquinone

Indexed keywords

BORTEZOMIB; CASPASE 3; CATALASE; CISPLATIN; DOXORUBICIN; FREE RADICAL; GEMCITABINE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NIGELLA SATIVA EXTRACT; OXALIPLATIN; PACLITAXEL; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; SUPEROXIDE; THYMOQUINONE;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTHRITIS; ASTHMA; BLACK CUMIN; BREAST ADENOCARCINOMA; CARCINOGENESIS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CARCINOMA; CROSSOVER PROCEDURE; DIABETES CONTROL; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENCEPHALOMYELITIS; FIBROBLAST; GLIOBLASTOMA; GLIOMA; HELICOBACTER INFECTION; HEPATITIS B; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY DISEASE; LEUKEMIA; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; METASTASIS; NEPHROTOXICITY; NEUROLOGIC DISEASE; NONHUMAN; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 84855810908     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.09.029     Document Type: Note

References (89)

1. M.S. Baliga Triphala, Ayurvedic formulation for treating and preventing cancer: a review J Altern Complement Med 16 2010 1301 1308
2. J. Mann Natural products in cancer chemotherapy: past, present and future Nat Rev Cancer 2 2002 143 148 (Pubitemid 37328801)
3. G.M. Cragg Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development Med Res Rev 18 1998 315 331 (Pubitemid 28419084)
4. H. Gali-Muhtasib, A. Roessner, and R. Schneider-Stock Thymoquinone: a promising anti-cancer drug from natural sources Int J Biochem Cell Biol 38 2006 1249 1253
5. M. Khader, N. Bresgen, and P.M. Eckl In vitro toxicological properties of thymoquinone Food Chem Toxicol 47 2009 129 133
6. V. Hajhashemi, A. Ghannadi, and H. Jafarabadi Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug Phytother Res 18 2004 195 199 (Pubitemid 38568744)
7. M. Burits, and F. Bucar Antioxidant activity of Nigella sativa essential oil Phytother Res 14 2000 323 328 (Pubitemid 30655515)
8. M. El-Dakhakhany Studies on the chemical constitution of Egyptian N. sativa L. seeds Planta Med 11 1963 465 470
9. L. Ferrero-Miliani, O.H. Nielsen, P.S. Andersen, and S.E. Girardin Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation Clin Exp Immunol 147 2007 227 235 (Pubitemid 46095999)
10. S. Reuter, S.C. Gupta, M.M. Chaturvedi, and B.B. Aggarwal Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49 2010 1603 1616
11. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
12. A. El-Mahmoudy, Y. Shimizu, T. Shiina, H. Matsuyama, M. El-Sayed, and T. Takewaki Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism Int Immunopharmacol 5 2005 195 207 (Pubitemid 39626705)
13. M. Kanter Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy Neurochem Res 33 2008 87 96 (Pubitemid 350242795)
14. L. Pari, and C. Sankaranarayanan Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats Life Sci 85 2009 830 834
15. N.E. Abdelmeguid, R. Fakhoury, S.M. Kamal, and R.J. Al Wafai Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats J Diabetes 2 2010 256 266
16. M. Kanter Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy J Mol Histol 40 2009 107 115
17. M. Budancamanak, M. Kanter, A. Demirel, A. Ocakci, H. Uysal, and C. Karakaya Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis Arch Toxicol 80 2006 768 776 (Pubitemid 44817816)
18. I. Tekeoglu, A. Dogan, and L. Demiralp Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models Phytother Res 20 2006 869 871 (Pubitemid 44606483)
19. F. Vaillancourt, P. Silva, Q. Shi, H. Fahmi, J.C. Fernandes, and M. Benderdour Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis J Cell Biochem 112 2011 107 117
20. L.A. Joosten, M.M. Helsen, F.A. van de Loo, and W.B. van den Berg Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra Arthritis Rheum 39 1996 797 809
21. M. El Gazzar, R. El Mezayen, J.C. Marecki, M.R. Nicolls, A. Canastar, and S.C. Dreskin Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation Int Immunopharmacol 6 2006 1135 1142 (Pubitemid 43728167)
22. M.A. Mansour, M.N. Nagi, A.S. El-Khatib, and A.M. Al-Bekairi Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action Cell Biochem Funct 20 2002 143 151
23. O.A. Badary, R.A. Taha, A.M. Gamal el-Din, and M.H. Abdel-Wahab Thymoquinone is a potent superoxide anion scavenger Drug Chem Toxicol 26 2003 87 98 (Pubitemid 36597385)
24. C. Sankaranarayanan, and L. Pari Thymoquinone ameliorates chemical induced oxidative stress and β-cell damage in experimental hyperglycemic rats Chem Biol Interact 190 2011 148 154
25. M.M. Sayed-Ahmed, A.M. Aleisa, S.S. Al-Rejaie, A.A. Al-Yahya, O.A. Al-Shabanah, and M.M. Hafez Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling Oxid Med Cell Longev 3 2010 254 261
26. A. Pompella, A. Visvikis, A. Paolicchi, V. De Tata, and A.F. Casini The changing faces of glutathione, a cellular protagonist Biochem Pharmacol 66 2003 1499 1503 (Pubitemid 38373339)
27. A. Mohamed, A. Shoker, F. Bendjelloul, A. Mare, M. Alzrigh, and H. Benghuzzi Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor Biomed Sci Instrum 39 2003 440 445 (Pubitemid 36433466)
28. M.M. Sayed-Ahmed, and M.N. Nagi Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats Clin Exp Pharmacol Physiol 34 2007 399 405 (Pubitemid 46494460)
29. K.S. Ahn, and B.B. Aggarwal Transcription factor NF-kappaB: a sensor for smoke and stress signals Ann NY Acad Sci 1056 2005 218 233 (Pubitemid 43030980)
30. N. Chehl, G. Chipitsyna, Q. Gong, C.J. Yeo, and H.A. Arafat Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells HPB (Oxford) 11 2009 373 381
31. G. Sethi, K.S. Ahn, and B.B. Aggarwal Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis Mol Cancer Res 6 2008 1059 1070
32. R. Wilkins, M. Tucci, and H. Benghuzzi Role of plant-derived antioxidants on NF-kb expression in LPS-stimulated macrophages Biomed Sci Instrum 47 2011 222 227
33. M.A. El Gazzar, R. El Mezayen, M.R. Nicolls, and S.C. Dreskin Thymoquinone attenuates proinflammatory responses in lipopolysaccharide- activated mast cells by modulating NF-kappaB nuclear transactivation Biochim Biophys Acta 1770 2007 556 564 (Pubitemid 46281476)
34. A. Mohamed, D.M. Afridi, O. Garani, and M. Tucci Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis Biomed Sci Instrum 41 2005 388 393
35. P.A. Johnston, and J.R. Grandis STAT3 signaling: anticancer strategies and challenges Mol Interventions 11 2011 18 26
36. J.E. Darnell Jr. Transcription factors as targets for cancer therapy Nat Rev Cancer 2 2002 740 749 (Pubitemid 37328909)
37. F. Li, P. Rajendran, and G. Sethi Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway Br J Pharmacol 161 2010 541 554
38. G. Germano, P. Allavena, and A. Mantovani Cytokines as a key component of cancer-related inflammation Cytokine 43 2008 374 379
39. M.A. El-Gazzar Thymoquinone suppresses in vitro production of IL-5 and IL-13 by mast cells in response to lipopolysaccharide stimulation Inflamm Res 56 2007 345 351
40. S. Banerjee, A.O. Kaseb, Z. Wang, D. Kong, M. Mohammad, and S. Padhye Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer Cancer Res 69 2009 5575 5583
41. R. El Mezayen, M. El Gazzar, M.R. Nicolls, J.C. Marecki, S.C. Dreskin, and H. Nomiyama Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation Immunol Lett 106 2006 72 81 (Pubitemid 44093055)
42. M. El Gazzar, R. El Mezayen, M.R. Nicolls, J.C. Marecki, and S.C. Dreskin Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma Biochim Biophys Acta 1760 2006 1088 1095 (Pubitemid 43867923)
43. M. Mansour, and S. Tornhamre Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone J Enzyme Inhib Med Chem 19 2004 431 436 (Pubitemid 40045504)
44. D.M. Parkin Global cancer statistics in the year 2000 Lancet Oncol 2 2000 533 543
45. S. Banerjee, S. Padhye, A. Azmi, Z. Wang, P.A. Philip, and O. Kucuk Review on molecular and therapeutic potential of thymoquinone in cancer Nutr Cancer 62 2010 938 946
46. O.A. Badary, O.A. Al-Shabanah, M.N. Nagi, A.C. Al-Rikabi, and M.M. Elmazar Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone Eur J Cancer Prev 8 1999 435 440 (Pubitemid 30048073)
47. O.A. Badary, and A.M. Gamal El-Din Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis Cancer Detect Prev 25 2001 362 368
48. S. Lapenna, and A. Giordano Cell cycle kinases as therapeutic targets for cancer Nat Rev Drug Discov 8 2009 547 566
49. H.U. Gali-Muhtasib, W.G. Abou Kheir, L.A. Kheir, N. Darwiche, and P.A. Crooks Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes Anticancer Drugs 15 2004 389 399 (Pubitemid 38526764)
50. V. Cecarini, L. Quassinti, A. Di Blasio, L. Bonfili, M. Bramucci, and G. Lupidi Effects of thymoquinone on isolated and cellular proteasomes FEBS J 277 2010 2128 2141
51. R.L. Gurung, S.N. Lim, A.K. Khaw, J.F. Soon, K. Shenoy, and S. Mohamed Ali Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells PLoS One 5 2010 e12124
52. K. Effenberger-Neidnicht, and R. Schobert Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin Cancer Chemother Pharmacol 67 2011 867 874
53. C.C. Woo, S.Y. Loo, G. Veronica, C.W. Yap, G. Sethi, and A.P. Kumar Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway Biochem Pharmacol 82 2011 464 475
54. M.A. El-Mahdy, Q. Zhu, Q.E. Wang, G. Wani, and A.A. Wani Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myoloblastic leukemia HL-60 cells Int J Cancer 117 2005 409 417 (Pubitemid 41429564)
55. M. Alhosin, A. Abusnina, M. Achour, T. Sharif, C. Muller, and J. Peluso Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1 Biochem Pharmacol 79 2010 1251 1260
56. S.H. Jafri, J. Glass, R. Shi, S. Zhang, M. Prince, and H. Kleiner-Hancock Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo J Exp Clin Cancer Res 29 2010 87
57. S. Rooney, and M.F. Ryan Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines Anticancer Res 25 2010 2199 2204 (Pubitemid 40904623)
58. N. El-Najjar, M. Chatila, H. Moukadem, H. Vuorela, M. Ocker, and M. Gandesiri Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling Apoptosis 15 2010 183 195
59. M. Roepke, A. Diestel, K. Bajbouj, D. Walluscheck, P. Schonfeld, and A. Roessner Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells Cancer Biol Ther 6 2007 160 169 (Pubitemid 46641618)
60. L.R. Richards, P. Jones, J. Hughes, H. Benghuzzi, and M. Tucci The physiological effect of conventional treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid on the LNCaP cell line Biomed Sci Instrum 42 2006 357 362
61. A.O. Kaseb, K. Chinnakannu, D. Chen, A. Sivanandam, S. Tejwani, and M. Menon Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer Cancer Res 67 2007 7782 7788 (Pubitemid 47281372)
62. P.S. Koka, D. Mondal, M. Schultz, A.B. Abdel-Mageed, and K.C. Agrawal Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species Exp Biol Med (Maywood) 235 2010 751 760
63. S. Ivankovic, R. Stojkovic, M. Jukic, M. Milos, M. Milos, and M. Jurin The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo Exp Oncol 28 2006 220 224 (Pubitemid 44735913)
64. H. Gali-Muhtasib, M. Diab-Assaf, C. Boltze, J. Al-Hmaira, R. Hartig, and A. Roessner Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism Int J Oncol 25 2004 857 866
65. Arafa el-SA, Q. Zhu, Z.I. Shah, G. Wani, B.M. Barakat, and I. Racoma Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells Mutat Res 706 2011 28 35
66. Q.X. Li, D.H. Yu, G. Liu, N. Ke, J. McKelvy, and F. Wong-Staal Selective anticancer strategies via intervention of the death pathways relevant to cell transformation Cell Death Differ 15 2008 1197 1210 (Pubitemid 351984750)
67. H. Gali-Muhtasib, D. Kuester, C. Mawrin, K. Bajbouj, A. Diestel, and M. Ocker Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells Cancer Res 68 2008 5609 5618
68. T. Yi, S.G. Cho, Z. Yi, X. Pang, M. Rodriguez, and Y. Wang Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways Mol Cancer Ther 7 2008 1789 1796
69. M.P. Torres, M.P. Ponnusamy, S. Chakraborty, L.M. Smith, S. Das, and H.A. Arafat Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies Mol Cancer Ther 9 2010 1419 1431
70. W.K. Ng, L.S. Yazan, and M. Ismail Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein Toxicol In Vitro 25 2011 1392 1398
71. A.R. Hussain, M. Ahmed, S. Ahmed, P. Manogaran, L.C. Platanias, and S.N. Alvi Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma Free Radic Biol Med 50 2011 978 987
72. J.L. Bolton, M.A. Trush, T.M. Penning, G. Dryhurst, and T.J. Monks Role of quinones in toxicology Chem Res Toxicol 13 2000 135 160 (Pubitemid 30169958)
73. R. Velho-Pereira, A. Kumar, B.N. Pandey, A.G. Jagtap, and K.P. Mishra Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis Cell Biol Int 2011
74. H. Gali-Muhtasib, M. Ocker, D. Kuester, S. Krueger, Z. El-Hajj, and A. Diestel Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models J Cell Mol Med 12 2008 330 342
75. A. Abusnina, M. Alhosin, T. Keravis, C.D. Muller, G. Fuhrmann, and C. Bronner Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis Cell Signal 23 2011 152 160
76. R.Y. Tsang, T. Al-Fayea, and H.J. Au Cisplatin overdose: toxicities and management Drug Saf 32 2009 1109 1122
77. O.A. Badary, M.N. Nagi, O.A. al-Shabanah, H.A. al-Sawaf, M.O. al-Sohaibani, and A.M. al-Bekairi Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity Can J Physiol Pharmacol 75 1997 1356 1361 (Pubitemid 28130377)
78. O.A. Al-Shabanah, O.A. Badary, M.N. Nagi, N.M. al-Gharably, A.C. al-Rikabi, and A.M. al-Bekairi Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity J Exp Clin Cancer Res 17 1998 193 198 (Pubitemid 28335578)
79. O.A. Badary, A.B. Abdel-Naim, M.H. Abdel-Wahab, and F.M. Hamada The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats Toxicology 143 2000 219 226 (Pubitemid 30089521)
80. M.N. Nagi, O.A. Al-Shabanah, M.M. Hafez, and M.M. Sayed-Ahmed Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats J Biochem Mol Toxicol 25 2010 135 142
81. A. Göke, S. Oktar, A. Koc, and Z. Yonden Protective effects of thymoquinone against methotrexate-induced testicular injury Hum Exp Toxicol 30 2010 897 903
82. M.N. Nagi, and H.A. Almakki Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity Phytother Res 23 2009 1295 1298
83. S. Breyer, K. Effenberger, and R. Schobert Effects of thymoquinone-fatty acid conjugates on cancer cells ChemMedChem 4 2009 761 768
84. J. Ravindran, H.B. Nair, B. Sung, S. Prasad, R.R. Tekmal, and B.B. Aggarwal Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential Biochem Pharmacol 79 2010 1640 1647
85. G.M. Ganea, S.O. Fakayode, J.N. Losso, C.F. van Nostrum, C.M. Sabliov, and I.M. Warner Delivery of phytochemical thymoquinone using molecular micelle modified poly(d, l lactide-co-glycolide) (PLGA) nanoparticles Nanotechnology 21 2010 285104
86. S. Banerjee, A.S. Azmi, S. Padhye, M.W. Singh, J.B. Baruah, and P.A. Philip Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer Pharm Res 27 2010 1146 1158
87. A.M. Al-Amri, and A.O. Bamosa Phase I safety and clinical activity study of thymoquinone in patients with advanced refractory malignant disease Shiraz E-Med J 10 2009 107 111
88. J. Akhondian, H. Kianifar, M. Raoofziaee, A. Moayedpour, M.B. Toosi, and M. Khajedaluee The effect of thymoquinone on intractable pediatric seizures (pilot study) Epilepsy Res 93 2011 39 43
89. O.A. Badary Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice J Ethnopharmacol 67 1999 135 142 (Pubitemid 29421667)